
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging
|
|||||
![]() A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging ![]() Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections. . . . → Read More: Stem Cells Help Severe Covid-19 Cases Recover ![]() A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy ![]() Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease. . . . → Read More: ALS Stem Cell Treatments Found Safe, Slow Progression ![]() Results of a clinical trial show a treatment for multiple sclerosis from patients’ stem cells slows progression of the disease and improves walking ability. . . . → Read More: Trial Shows Stem Cell Therapy Slows M.S. Progression ![]() A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies ![]() Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal ![]() Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective ![]() Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases. . . . → Read More: Crispr Therapy Shown to Help Blood Disorder Patients ![]() The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes. . . . → Read More: FDA to Use Lung Chip Model for Covid-19 Testing |
|||||
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |